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Abstract
AIM: To determine whether previously identified risk factors are associated with the development of a severe form of 
pre-eclampsia in a heterogeneous cohort of women, and the predictive values of these risk factors when combined 
with certain biochemical indicators.
MATERIALS AND METHODS: Systematic review of data collected for a doctoral case-control study plus an 
examination of the indicators of pre-eclampsia and maternal IL10 levels. This examination was conducted in 
100 women with pregnancies complicated by varying degrees of pre-eclampsia and in 80 normotensive patients 
hospitalized at the University Clinic of Gynecology and Obstetrics, Skopje, Republic of Macedonia. Patients with pre-
eclampsia were categorized into moderate (m PE) and severe (s PE) pre-eclampsia group according to the degree 
of pre-eclampsia. The severity of pre-eclampsia was determined according to the definition of the World Health 
Organization, Handbook for guideline development from 2010.
RESULTS: The regression analysis applied in this study showed that elevated systolic blood pressure of 160 
mmHg or higher, diastolic blood pressure of 100 mmHg or higher, pregnancy at an older age, nulliparity, persistent 
proteinuria in pregnancy, the serum lactate dehydrogenase concentration of 450 U/L or higher, and reduced serum 
concentrations of IL10 as significant predictors of severe pre-eclampsia in pregnant women. While other variables 
predicted a higher likelihood for the development of severe pre-eclampsia, IL10 decreased such likelihood. IL10 was 
also found to be negatively correlated with proteinuria and positively correlated with blood platelets. Significantly 
higher concentration of IL10 was confirmed in patients with a higher number of platelets in the blood and vice versa. 
On the other hand, the serum concentration of IL10 was significantly lower in patients with a higher amount of 
proteins in the urine and vice versa.
CONCLUSIONS: Examination of clinical risk factors combined with biochemical markers can improve the predictive 
success of pre-eclampsia and has important clinical values in improving the prognosis of pregnant women and 
fetuses.
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Introduction
Pre-eclampsia, defined as the onset of 
hypertension and the presence of protein in the urine 
at >20 weeks of gestation in a previously normotensive 
woman, is a pregnancy complication that is still one 
of the leading causes of death and disability of both 
mother and babies. Pre-eclampsia occurs in 5-8% of 
pregnancies in developed countries [1], [2], [3].
Risk factors for pre-eclampsia that have been 
identified in previous studies include both young and 
old maternal age, high BMI, prior pregnancy with pre-
eclampsia, excessive weight gain during pregnancy, 
nulliparity, chronic hypertension, low socioeconomic 
status, prolonged birth interval, race and ethnicity, 
genetic predisposition, environmental, and even 
seasonal influences. Ironically, although smoking during 
pregnancy causes various adverse pregnancy outcomes 
when it comes to pre-eclampsia and hypertensive 
disorders in pregnancy, many studies have shown that it 
is associated with reduced risk [4], [5], [6].
The role of immune mechanisms contributing 
to the development of a normal pregnancy is widely 
discussed. Their involvement in the pathogenesis of 
pregnancy complications, such as pre-eclampsia, 
was also noted. The analysis of the scientific literature 
reveals the conclusion that many aspects of the 
pathogenesis of pre-eclampsia are related to systemic 
inflammatory response syndrome with the development 
of a destructive inflammatory process, immune 
disorders, and the imbalance of cytokine regulation of 
gestation processes [7], [8].
The role of vascular endothelial damage with 
the development of generalized arteriolar spasm as one 
of the leading mechanisms in the pathogenesis of pre-
eclampsia is supposed to be significant. However, the 
relationship between the development of endothelial 
dysfunction and disruption of cytokine regulation in 
different clinical forms of pre-eclampsia also requires 
further research and is currently represented in several 
scientific works [9].
Proteinuria has been proposed and studied 
as both an indicator of the severity of the disease and 
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as a predictor of the outcome in pre-eclampsia. Many 
clinicians still make major management decisions 
based on the degree of proteinuria in these patients.
The quantity of protein that is excreted in the 
urine varies widely. Significant protein excretion is 
defined as ≥300 mg in a 24-h urine collection or 1+ or 
greater on urine dipstick testing of two random urine 
samples that are collected at least 4 h apart [10].
The serum uric acid level once was used as 
an indicator of pre-eclampsia, but it has been found 
to lack sensitivity and specificity as a diagnostic tool. 
However, an elevated serum uric acid level may be of 
some use in identifying pregnant women with chronic 
hypertension who have an increased likelihood of 
having superimposed pre-eclampsia.
A lactate dehydrogenase (LD or LDH) test is 
a non-specific test that may be used in the evaluation 
of a number of diseases and conditions. Thus, the 
blood level of LD is a general indicator of tissue and 
cellular damage and it is used as one of the indicators 
of pre-eclampsia. Several studies have confirmed the 
accentuation of platelet activation in pre-eclampsia 
which remains an important obstetric complication 
affecting 2–4% of all pregnancies. Detection of 
aberrations of platelet function and activation appears 
to have predictive value for the diagnosis [11].
Studies showed that in pregnancy complicated 
by pre-eclampsia, cytokine levels essentially change 
compared with the respective levels in physiological 
pregnancy. Thus, even a moderate form of pre-
eclampsia shows directional change, that is, elevated 
levels of pro- and anti-inflammatory cytokines, with the 
exception of IL-10, wherein a downward trend in severe 
pre-eclampsia is recorded [10], [11].
We carried out this study to estimate the risk 
of developing different forms of pre-eclampsia for each 
demographic and clinical risk factor as to evaluate the 
relationship between the formation of anti-inflammatory 
IL10 cytokine and several indicators of moderate and 
severe pre-eclampsia.
This will provide an evidence base from which 
health-care professionals can assess each pregnant 
woman’s risk of pre-eclampsia at her first antenatal 
visit and arrange her antenatal care according to 
need.
Material and Methods
Univariant logistic regression analysis 
was used for determination of the predictive role of 
certain sociodemographic, clinical, and biochemical 
parameters for severe pre-eclampsia.
Statistical data analysis was performed using 
the SPSS statistical package for Windows, version 
13.0. Logistic regression analysis (binary logistic 
regression) was used to determine the predictive value 
of the different parameters for the occurrence of severe 
pre-eclampsia. Rates of probability – odds ratios (OR) 
and 95% confidence intervals (CI) were calculated to 
quantify independent associations.
Results
Maternal age
Maternal age of patients with non-severe and 
severe pre-eclampsia was analyzed into two categories: 
Older than 35 and younger than 35 years. The results 
showed that 16% from the patients with a non-severe 
form of pre-eclampsia and 52% form the patients with a 
severe form of pre-eclampsia were older than 35 years. 
The statistical analysis confirmed that pregnant women 
older than 35 years, highly significant, have a severe 
form of pre-eclampsia (p = 0.007) (Figure 1).
Figure 1: Age groups – non-severe and severe PE. Pearson Chi-
square: 7.21 df = 1, p = 0.007**, p<0.01
The age of the respondents analyzed as a 
continuous variable has confirmed itself as a highly 
significant predictor for the severe form of eclampsia 
(p = 0.004). Advancing the age for another year 
increases the probability for getting a severe form of 
eclampsia during the pregnancy for 26.3% (95.0% CI 
1.08–1.478) (Table 1).
Table 1: Univariant logistic regression analysis – the meaning 
of age in the prediction of severe eclampsia
Variable B SE Wald Sig. Exp (B) 95.0% CI for Exp (B)
Age 0.234 0.080 8.510 0.004** 1.263 1.080 1.478
Constant −7.510 2.603 8.323 0.004 0.001
Dependent variable – severe eclampsia/non-severe pre-eclampsia **p<0.01.
The age analysis as a categorical variable in 
two age groups (older and younger than 35 years) has 
shown that pregnant women older than 35 years are in 
5.687 times (95.0% CI 1.510–21.424) bigger risk from 
the pregnant women aged 35 and younger to develop a 
severe form of gestosis (Tables 2 and 3).
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Table 2: Univariant logistic regression analysis – age over 35 
years for prediction of severe eclampsia
Variable B SE Wald Sig. Exp (B) 95.0% CI for Exp (B)
Age >35 1.738234 0.677 6.599 0.01** 5.687 1.510 21.424
Constant −0.56 0.362 2.391 0.122 0.571
Dependent variable – severe eclampsia/medium eclampsia **p<0.01.
Gestation
The probability for getting a severe form of pre-
eclampsia insignificantly decreases with the increase of 
the gestation length of the pregnant women (p = 0.271). 
If the pregnancy continues for one more gestational 
week, the chance for getting a severe form of pre-
eclampsia decreases for 8.8% (95.0% CI 0.775–1.74) 
(Table 3).
Table 3: Univariant logistic regression analysis – gestational 
age in the prediction for severe eclampsia
Variable B SE Wald Sig. Exp (B) 95.0% CI for Exp (B)
Gestation −0.092 0.083 1.211 0.271 0.912 0.775 1.74
Constant 3.211 2.935 1.197 0.274 24.796
Dependent variable – severe eclampsia/ medium eclampsia.
BMI
For the level of significance of p = 0.05, the 
results of the survey have confirmed the value of BMI 
as an insignificant factor for severe gestosis (p = 0.059) 
(Table 4).
Table 4: Univariant logistic regression analysis – BMI in the 
prediction of severe eclampsia
Variable B SE Wald Sig. Exp (B) 95.0% CI for Exp (B)
BMI 0.131 0.070 3.562 0.059 1.140 0.995 1.307
Constant −4.505 2.407 3.504 0.061 0.011
Dependent variable – severe eclampsia/ medium eclampsia.
Nulliparity
The nulliparity represents a highly significant 
risk factor for a severe form of pre-eclampsia (p = 0.006). 
Pregnant women without a history for previous delivery 
are in 5.63 times (95.0% CI 1.648–19.232) higher risk 
than the pregnant women who previously gave birth for 
getting a severe form of pre-eclampsia (Table 5).
Table 5: Univariant logistic regression analysis – zero parity in 
the prediction of severe eclampsia
Variable B SE Wald Sig. Exp (B) 95.0% CI for Exp (B)
Zero parity 1.728 0.627 7.600 0.006** 5.630 1.648 19.232
Constant −0.981 0.479 4.198 0.04 0.375
Dependent variable – severe eclampsia/ medium eclampsia **p<0.01.
Number of pregnancies
The number of pregnancies is an insignificant 
risk factor for a severe form of pre-eclampsia (p = 0.882). 
Pregnant women with two pregnancies have 0.857 
times (95.0% CI 0.111–6.617) insignificantly smaller 
chance than the ones with one pregnancy to develop a 
severe form of gestosis (Table 6).
Table 6: Univariant logistic regression analysis – The number of 
pregnancies in the prediction of severe eclampsia
Variable B SE Wald Sig. Exp (B) 95.0% CI for Exp (B)
Number of pregnancies −0.154 1.043 0.022 0.882 0.857 0.111 6.617
Constant −1.099 0.667 2.716 0.099 0.333
Dependent variable – severe eclampsia/ non-severe eclampsia.
Previous pre-eclampsia
The results of our survey did not show that previous 
pre-eclampsia significantly increases the chance for getting 
a severe form of pre-eclampsia (p = 0.215). Pregnant 
women with a history for the previous pre-eclampsia have 
3.028 times insignificantly larger probability from those with 
negative history for the previous pre-eclampsia to develop 
a severe form of gestosis (Table 7).
Smoking status
Smoking cigarettes insignificantly increases 
the risk for severe pre-eclampsia (p = 0.096). Pregnant 
women that are smokers are in 3.15 times insignificantly 
higher risk than the pregnant women that are non-
smokers for getting severe pre-eclampsia (Table 8).
Table 8: Univariant logistic regression analysis – previous pre-
eclampsia in the prediction of severe eclampsia
Variable B SE Wald Sig. Exp (B) 95.0% CI for Exp (B)
Smoker 1.147 0.689 2.769 0.096 3.150 0.815 12.168
Constant −0.336 0.338 0.991 0.320 0.714
Dependent variable – severe eclampsia/ non-severe eclampsia.
Diabetes mellitus
Diabetes Type 1, Type 2, or gestation diabetes 
are insignificantly associated with a severe form of pre-
eclampsia in the pregnancy (p = 0.364). The chances for 
getting severe eclampsia increase 2.3 times insignificantly 
for pregnant women with diabetes mellitus compared 
with pregnant women without diabetes (Table 9).
Table 9: Univariant logistic regression analysis – diabetes 
mellitus in the prediction of severe eclampsia
Variable B SE Wald Sig. Exp (B) 95.0% CI for Exp (B)
Diabetes 0.833 0.918 0.822 0.364 2.300 0.380 13.915
Constant −0.140 0.306 0.209 0.648 0.870
Dependent variable – severe eclampsia/non-severe pre-eclampsia.
Systolic blood pressure
Systolic blood pressure form 160 mmHg and 
higher is measured at 20% from the group with a non-
severe form of eclampsia, and at 92% from the group 
with a severe form. The difference in the distribution 
of respondents with values of systolic blood pressure 
higher and lower than 160 mmHg statistically is highly 
significant (p = 0.01) (Figure 2).
Table 7: Univariant logistic regression analysis – previous pre-
eclampsia in the prediction of severe eclampsia
Variable B SE Wald Sig. Exp (B) 95.0% CI for Exp (B)
Previous PE 1.107 0.892 1.540 0.215 3.028 0.527 17.394
Constant −0.191 0.310 0.380 0.538 0.828
Dependent variable – severe eclampsia/ non-severe eclampsia.
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Figure 2: Systolic blood pressure – non-severe and severe PE. 
Pearson Chi-square: 26.29 df = 1, p = 0.000**, p < 0.01
Systolic blood pressure analyzed as a 
continuous variable has confirmed itself as a highly 
significant predictor for severe gestosis in pregnancy 
(p = 0.001). The increase of systolic blood pressure for 
1 mmHgза 25% (95.0% CI 1.009–1.423) increases the 
probability for severe eclampsia (Table 10).
Table 10: Univariant logistic regression analysis – systolic 
blood pressure in the prediction of severe eclampsia
Variable B SE Wald Sig. Exp (B) 95.0% CI for Exp (B)
Systolic pressure 0.224 0.066 11.464 0.001** 1.250 1.099 1.423
Constant −35.524 10.558 11.321 0.001 0.000
Dependent variable – severe eclampsia/ non-severe eclampsia **p<0.01.
Pregnant women who have systolic blood 
pressure 160 mmHg and higher have 46 times (95.0% CI 
8.027–1.423) significantly higher chance than pregnant 
women with systolic blood pressure lower than 160 mmHg 
to develop a severe form of pre-eclampsia (Table 11).
Table 11: Univariant logistic regression analysis – systolic 
blood pressure higher than 160 mmHg in prediction of severe 
eclampsia
Variable B SE Wald Sig. Exp (B) 95.0% CI for Exp (B)
Systolic pressure > 
160 mmHg
3.829 0.891 18.474 0.000** 46.0 8.027 263.625
Constant −2.303 0.742 9.64 0.002 0.1
Dependent variable – severe eclampsia/ non-severe eclampsia.
Diastolic blood pressure
Diastolic blood pressure from 100 mmHg and 
higher more often had the respondents from the group 
with severe pre-eclampsia compared with the ones 
from the group with non-severe pre-eclampsia (88% vs. 
44%) (Figure 3).
Figure 3: Diastolic blood pressure – medium and severe PE. Pearson 
Chi-square: 12.5, df = 1, p = 0.0004**, p < 0.01
Diastolic blood pressure highly significant 
can predict the phenomenon of severe gestosis in 
pregnancy (p = 0.000). The increasing of the diastolic 
blood pressure for 1 mmHg increases the probability 
for severe pre-eclampsia for 29.8% (95.0% CI 1.129–
1.492) (Table 12).
Table 12: Univariant logistic regression analysis – diastolic 
blood pressure higher than 160 mmHg in the prediction of 
severe eclampsia
Variable B SE Wald Sig. Exp (B) 95.0% CI for Exp (B)
Diastolic pressure 0.261 0.071 13.456 0.000** 1.298 1.129 1.492
Constant −26.505 7.158 13.710 0.001 0.000
Dependent variable – severe eclampsia/ medium eclampsia **p<0.01.
Pregnant women who have diastolic blood 
pressure 100 mmHg and higher have 11 times 
significantly higher chance than pregnant women 
with diastolic blood pressure lower than 100 mmHg to 
develop a severe form of eclampsia (Table 13).
Table 13: Univariant logistic regression analysis – diastolic 
blood pressure higher than 160 mmHg in the prediction of 
severe pre-eclampsia
Variable B SE Wald Sig. Exp (B) 95.0% CI for Exp (B)
Diastolic pressure 
=>100 mmHg
2.398 0.739 10.541 0.001** 11.0 2.587 46.779
Constant −1.609 0.632 6.476 0.001 0.2
Dependent variable – severe eclampsia/ non-severe eclampsia **p<0.01.
Knowing that the pregnancy is a condition 
that requires immunological tolerance, it is widely 
accepted that immune mechanisms are involved in 
the pathogenesis of pregnancy complications such 
as pre-eclampsia. Studies showed that in pregnancy 
complicated by pre-eclampsia, cytokine levels 
essentially change compared with the respective levels 
in physiological pregnancy. Thus, even a moderate 
form of pre-eclampsia shows directional change, that is, 
elevated levels of pro- and anti-inflammatory cytokines, 
with the exception of IL-10, wherein a downward trend 
in severe pre-eclampsia is recorded.
The purpose of the actual study was to 
evaluate the relationship between the formation of 
anti-inflammatory IL10 cytokine and several indicators 
of moderate and severe pre-eclampsia in the third 
trimester of pregnancy.
Regarding patients’ distribution by ethnicity, 
Albanians represented more than half of women with 
pre-eclampsia, as well as 44% of participants with 
symptoms of medium, and 68% with symptoms of 
severe PE. Pregnant Albanians (68%) dominate in the 
group with normal tension. 
The average BMI in the group of pregnant 
women with pre-eclampsia was 34.33 ± 4.5 that 
was not significantly higher than the average body 
mass of the control group (32.8 8 ± 3.8) (p = 0.09). 
However, the difference between the average BMI 
of pregnant women with moderate and severe PE 
and normotensive pregnant patients was significant 
(F = 3.8, p = 0.026). Namely, pregnant women with 
severe PE had significantly higher average BMI than 
normotensive pregnant women (35.57 ± 4.1 vs. 32.88 ± 
3.8; p = 0.025) (Table 14).
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Statistical analysis showed no significant 
differences in the levels of IL10 in serum between 
pregnant women with pre-eclampsia and healthy pregnant 
women (p = 0.5), but the difference between moderate 
pre-eclampsia, severe pre-eclampsia, and control group 
was highly significant (p < 0.01) due to the lower levels of 
this interleukin in severe pre-eclampsia group, comparing 
moderate pre-eclampsia in relation to the control, and due 
to the highly significant lower values when comparing 
control in relation to moderate pre-eclampsia group. 
Average concentrations of IL10 in serum were 23.2 ± 40.7 
pg/ml in the total group of pre-eclampsia patients, 45.5 ± 
48.4 pg/ml in the group with moderate pre-eclampsia, and 
0.8 ± 0.4 pg/ml in the group with severe pre-eclampsia. 
In patients with normal-tension, the average serum 
concentration of IL10 was 4.2 ± 6.7 pg/ml.
Study data demonstrated that in pregnant 
women with pregnancy complicated by pre-eclampsia, 
the serum concentration of anti-inflammatory IL10 is 
confirmed as a significant predictor of the occurrence of 
severe pre-eclampsia. Increased serum concentrations of 
IL10 (in pg/mL) reduced the likelihood of the development 
of severe pre-eclampsia by 89.6% (95% CI 0.016–0.678).
Figures 4-6 show the results of bivariate 
analysis of the relationships between serum maternal 
concentration of IL10 and serum enzyme LDH, creatinine, 
platelets, proteinuria, and uric acid, respectively. 
The obtained values of Pearson’s coefficients 
indicate negative correlations of IL10 with LDH and 
proteinuria, whereas the correlations of IL10 with 
creatinine, platelets, and uric acid were positive. 
However, significant correlations were confirmed only 
between IL10 and platelets as well as between IL10 
and proteinuria. The correlation with the platelet count 
was positive which means that significantly higher 
concentration of IL10 was confirmed in patients with a 
higher number of platelets in the blood, and vice versa. 
The correlation between IL10 and proteinuria was 
negative, showing that the serum concentration of IL10 
was significantly lower in patients with a higher amount 
of proteins in the urine, and vice versa.
Discussion
This study demonstrates differences in IL10 
levels in women with pre-eclampsia compared to the 
levels in women with a normal pregnancy outcome.
Figure 4: Correlation IL10/LDH. r =−0.215; p = 0.134
Table 14: Age, gestational week, BMI, and IL10 serum concentration in women with moderate and severe pre-eclampsia, and women 
with normal blood pressure (control group)
Variable Groups
All PE n=50 Moderate PE (mPE) n=25 Severe PE (sPE) n=25 Control (C) n=50
Age (years) mean±SD 32.06 ± 4.8 29.9 ± 4.7 34.2 ± 3.85 31.8 ± 4.8
All PE/C; t=0.27; p=0.8
mPE/sPE/C; F=5.5; p=0.005 Post hoc mPE/sPE p=0.004
Gestational week mean ± SD 34.99 ± 3.5 35.5 ± 3.4 34.4 ± 3.6 34.8 ± 3.6
All PE/C; t=0.2; p=0.8
mPE/sPE/C; F=0.6; p=0.5
Ethnicity n (%)
Macedonian 18 (36) 10 (40) 8 (32) 15 (30)
Albanian 28 (56) 11 (44) 17 (68) 34 (68)
Romani 4 (8) 4 (16) 0 1 (2)
BMI mean ± SD, range 34.33 ± 4.5, 24.2–44 33.1 ± 4.7, 24.2–41 35.57 ± 4.1, 27–44 32.88 ± 3.8, 27–43.9
All PE/C; t=1.7; p=0.09.
Table 15: Multivariate logistic regression analysis for the factors predictors of severe pre-eclampsia
Variable B SE Wald p-value Exp (B) 95% CI for Exp (B)
Age (years) 0.2 0.086 5.350 0.021 1.221 1.031 1.446
Nulliparity (present) 1.816 1.114 2.657 0.103 6.145 0.692 54.534
Systolic blood pressure (≥160 mmHg) 3.711 1.053 12.412 <0.001 40.9 5.189 322.371
Diastolic blood pressure (≥100 mmHg) 2.414 0.843 8.192 0.004 11.176 2.140 58.360
Proteinuria (present) 3.081 1.307 5.56 0.018 21.785 1.682 282.123
LDH ≥450 (U/L) 2.066 0.915 5.102 0.024 7.896 1.314 47.433
Albumin (serum) (g/L) −0.239 0.125 3.66 0.056 0.787 0.616 1.006
Creatinine (serum) (umol/L) −0.067 0.035 3.696 0.055 0.935 0.873 1.001
Platelets (≤150 000) −0.006 0.013 0.236 0.627 0.994 0.97 1.019
IL10 (pg/ml) −2.324 1.051 4.888 0.027 0.098 0.012 0.768
Dependent variable: Severe pre-eclampsia.
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We found that in pregnant women with pre-
eclampsia, the increased serum concentrations of 
IL10 predicted a lower likelihood for the development 
of severe pre-eclampsia. IL10 has been identified as 
an important cytokine in pregnancy. It may be involved 
in the maintenance of pregnancy by corpus luteum 
maturation and progesterone production [12]. Ovarian 
corpus luteum cell growth was stimulated by exogenous 
IL10 and also in the presence of Th2 type lymphocytes 
derived during early pregnancy. In a well-known mouse 
cross that is prone to spontaneous abortion, a deficiency 
of IL10 has been demonstrated to alter the net fetal 
number and outcome [13]. Longitudinal studies in mice 
demonstrate a sequential change in the cytokine profile, 
including IL10 in peripheral blood and release from 
spleen elements as pregnancy advances [14], [15]. 
IL10 inhibition in the second half of pregnancy in mice 
causes fetal growth retardation [16]. Progesterone 
has been shown to increase Th2-type responses in T 
cells [17]. Taken together, these data suggest that early 
pregnancy is associated with an increase in circulating 
Th2 cytokine IL10.
This study demonstrated that there is a 
significant alteration in the serum concentration of 
IL10 in severe pre-eclampsia compared with normal 
pregnancy and in moderate pre-eclampsia groups of 
patients.
The regression analysis applied in this 
study showed systolic blood pressure of 160 mmHg 
or higher, diastolic blood pressure of 100 mmHg or 
higher, persistent proteinuria in pregnancy, the serum 
LDH concentration of 450 U/L or higher and reduced 
serum concentrations of IL10 as significant predictors 
of severe pre-eclampsia in pregnant women. While 
other variables predicted a higher likelihood for the 
development of severe pre-eclampsia, IL10 decreased 
such likelihood. IL10 was also found to be negatively 
correlated with proteinuria and positively correlated 
with blood platelets. Significantly higher concentration 
of IL10 was confirmed in patients with a higher number 
of platelets in the blood, and vice versa. On the other 
hand, the serum concentration of IL10 was significantly 
lower in patients with a higher amount of proteins in the 
urine, and vice versa (Table 15).
The actual study demonstrated platelet count 
and proteinuria as significant predictors of serum IL10 
concentration – platelets count predicting higher serum 
concentration of IL10, while urine proteins predicting 
lower serum IL10.
Some studies suggest a proportional link 
between the level of proteinuria and adverse clinical 
outcomes. Page et al., in a prospective study of 
almost 13,000 pregnant women, found that significant 
proteinuria, defined as 2+ or more on dipstick analysis, 
was associated with an increase in stillbirth rates, 
fetal growth restriction, and neonatal morbidity when 
associated with hypertension [18]. Other studies 
suggest that it is the presence of proteinuria rather 
than the severity, which is associated with poorer 
outcomes. There is evidence that even the finding of 
trace proteinuria in pregnant women with hypertension 
is associated with an increase in an adverse outcome.
Taking into consideration changes of anti-
inflammatory cytokine concentrations in severe pre-
eclampsia, a moderate phase can be analyzed as a 
critical stage in complicated pregnancies.
It can be assumed that moderately aggressive 
factors have a role as initiators of synthesis of mediators 
of intercellular interaction (in moderate pre-eclampsia) 
Figure 6: Correlation IL10/platelets. r = 0.362; p = 0.01
Figure 5: Correlation IL10/creatinine. r = 0.134; p = 0.355
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and the development of immune response is regulated 
by the interaction of cytokines and their antagonists. 
With the increasing severity of the pathological process, 
the impact of regulatory factors that limit the systemic 
effect is reduced.
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